脑脊液和血瘦素的动态在女性腹手术后
Adriana Pané1,2,3, Laura Videla4,5,6, Judith Viaplana7
1Endocrinology and Nutrition Department, Hospital Clínic, Barcelona, Spain.
The Journal of clinical endocrinology and metabolism
|January 8, 2026
概括
腹腔外科手术通过增加脑脊髓液 (CSF) 与血中瘦素的比率,改善了肥胖妇女的脑瘦素运输. 这表明与肥胖相关的瘦素运输问题是可逆的,随着体重减轻.
科学领域:
- 内分泌学 在内分泌学.
- 神经科学是一个神经科学.
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 肥胖与瘦素耐药性有关,可能是由于大脑瘦素运输受损.
- 了解瘦素动态对于管理肥胖及其代谢后果至关重要.
研究的目的:
- 为了评估血和脑脊液 (CSF) 瘦素在减肥手术 (BS) 之前和之后的动态.
- 探索丁动态和BS后的减肥轨迹之间的关系.
主要方法:
- 对33名肥胖女性和13名对照女性进行了前性纵向研究.
- 测量了血和脑液中瘦素水平,在基线和BS后一年内计算了脑液与血中的瘦素比例.
- 在BS.之后的四年里,每年监测体重.
主要成果:
- 肥胖妇女在基线时血/脑流中瘦素水平升高,脑流与血中瘦素比例降低.
- 腹腔外科手术显著提高了瘦素运输效率.
- 无论是基线还是术后的瘦素水平都没有预测体重减轻或长期体重轨迹.
结论:
- 与肥胖相关的瘦素运输变化可能是可逆的,与肥胖状态有关,而不是内在缺陷.
- 通过减肥手术实现的减肥可以恢复正常的大脑瘦素运输机制.
相关概念视频
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
235
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
235
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
165
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
165


